Lion Biotechnologies to Present at the 26th Annual ROTH Conference
March 04 2014 - 8:00AM
Lion Biotechnologies, Inc. (OTCQB:LBIO) announced that Chief
Executive Officer Manish Singh, Ph.D., will present at the 26th
Annual ROTH Conference on Tuesday, March 11, 2014, at 1:00 p.m.
Pacific in Salon 5. The conference is being held at The Ritz
Carlton in Dana Point, California, from March 9-12, 2014.
This event is designed to provide investors with a unique
opportunity to gain insight into emerging growth companies across a
variety of sectors, including Cleantech, Consumer & Retail,
Energy & Industrial, Enterprise Software, Healthcare,
Resources, Semiconductors & Electronics, Services and
Technology & Media.
A webcast of Dr. Singh's presentation will be available both
live and on replay. The presentation will be available via webcast
at http://wsw.com/webcast/roth28/LBIO. A replay will also be
available for 90 days following the live presentation. The live
webcast and subsequent archived replay of Lion Biotechnologies'
presentation will also be accessible via the Investors section of
the Company's web site at http://lbio.com/investors/ under "Recent
Events."
About Lion Biotechnologies
Lion Biotechnologies, Inc. is engaged in the development of
T-cells and engineered T-cells for the treatment of various
cancers. The company's lead product candidate is a ready-to-infuse
autologous T-cell therapy utilizing tumor-infiltrating lymphocytes
(TILs) for the treatment of patients with Stage IV metastatic
melanoma, and is based on a clinical CRADA with the National Cancer
Institute along with physician-sponsored investigational therapy at
the MD Anderson Cancer Center and the H. Lee Moffitt Cancer &
Research Institute. For more information, please visit
http://www.lionbio.com.
CONTACT: Investor Relations
The Trout Group
Gitanjali Jain Ogawa
646-378-2949
gogawa@troutgroup.com